Andrea Mattarei
Papers
1
Total Citations
6
H-Index
1
About
Dr. Andrea Mattarei is a leading researcher in neuropsychopharmacology, with a primary focus on the therapeutic potential of esmethadone (REL-1017) for treatment-resistant psychiatric conditions. His major contributions center on investigating rapid-acting antidepressants and their effects on complex, often underdiagnosed symptom clusters. In his notable 2022 work, "REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants," Mattarei addresses a critical gap in psychiatry: the high prevalence of dissociative disorders (29% in outpatient populations) and their frequent misdiagnosis (only 5% previously identified). This study, garnering 6 citations, demonstrates that esmethadone can rapidly alleviate dissociative symptoms in patients with major depressive disorder who have not responded to standard treatments. By highlighting the intersection of depression and dissociation, Mattarei's research pushes for more nuanced diagnostic and therapeutic approaches, offering new hope for patients with refractory symptoms. His work underscores the importance of targeting overlooked comorbidities in psychiatric care, making him a pivotal figure in advancing personalized, mechanism-based treatments for severe mental illness.
Research Focus
Key Achievements
Top Papers
- 1